We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32.6B
AUM Growth
+$1.87B
Cap. Flow
+$3.25B
Cap. Flow %
9.96%
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$197M
2
TDG icon
TransDigm Group
TDG
+$181M
3
AAPL icon
Apple
AAPL
+$148M
4
ORCL icon
Oracle
ORCL
+$133M
5
ACC
American Campus Communities, Inc.
ACC
+$128M

Sector Composition

Rank Sector Weight
1 Industrials 11.6%
2 Technology 10.81%
3 Financials 10.76%
4 Consumer Discretionary 10.14%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
2426
TG Therapeutics
TGTX
$7.35B
$62K ﹤0.01%
+10,499
New +$68.9K
OWLT.WS
2427
DELISTED
Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
OWLT.WS
$62K ﹤0.01%
500,000
ML.WS
2428
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$60K ﹤0.01%
500,000
OVID icon
2429
Ovid Therapeutics
OVID
$517M
$59K ﹤0.01%
+31,938
New +$66.8K
ROIVW
2430
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$59K ﹤0.01%
150,000
RENEW
2431
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$58K ﹤0.01%
+400,000
New +$67.2K
AKTS
2432
DELISTED
Akoustis Technologies Inc
AKTS
$58K ﹤0.01%
19,662
-18,919
-49% -$76.8K
SRTA
2433
Strata Critical Medical Inc
SRTA
$524M
$57K ﹤0.01%
+14,033
New +$72.1K
PRAX icon
2434
Praxis Precision Medicines
PRAX
$10.2B
$57K ﹤0.01%
+1,671
New +$83.3K
SRNE
2435
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$57K ﹤0.01%
36,094
-25,352
-41% -$57.5K
LOCC.WS
2436
DELISTED
Live Oak Crestview Climate Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOCC.WS
$57K ﹤0.01%
166,666
CURV icon
2437
Torrid Holdings
CURV
$224M
$56K ﹤0.01%
+13,474
New +$70.6K
FOSL icon
2438
Fossil Group
FOSL
$321M
$56K ﹤0.01%
16,385
-50,960
-76% -$261K
ARGUW
2439
DELISTED
Argus Capital Corp. Warrant
ARGUW
$56K ﹤0.01%
375,000
LUXAW
2440
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$56K ﹤0.01%
414,170
CDE icon
2441
Coeur Mining
CDE
$19.8B
$55K ﹤0.01%
16,095
-18,206
-53% -$54K
HBIO icon
2442
Harvard Bioscience
HBIO
$30.1M
$55K ﹤0.01%
+2,151
New +$71.2K
IMMP
2443
Immutep
IMMP
$58M
$55K ﹤0.01%
+35,173
New +$71.5K
OUST icon
2444
Ouster
OUST
$3.41B
$55K ﹤0.01%
+5,749
New +$88.5K
GPUS
2445
Hyperscale Data Inc
GPUS
$43.9M
$55K ﹤0.01%
+2
New +$92.5K
CVIIW
2446
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$54K ﹤0.01%
397,660
MAPS
2447
DELISTED
WM TECHNOLOGY INC A
MAPS
$53K ﹤0.01%
+32,831
New +$93.2K
BRDS
2448
DELISTED
Bird Global, Inc.
BRDS
$53K ﹤0.01%
6,000
AMBP icon
2449
Ardagh Metal Packaging
AMBP
$3.11B
$51K ﹤0.01%
10,437
-118,563
-92% -$723K
UEC icon
2450
Uranium Energy
UEC
$5.69B
$51K ﹤0.01%
+14,435
New +$55.2K

Similar funds

Balyasny Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Balyasny Asset Management held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Balyasny Asset Management deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.

  • Balyasny Asset Management's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
  • Balyasny Asset Management's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
  • Balyasny Asset Management fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
  • Balyasny Asset Management's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
  • Balyasny Asset Management opened 825 new positions and closed 693 in Q3 2022.
  • Balyasny Asset Management's portfolio value rose 6.1% quarter-over-quarter to $32.6B.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.